Scarica l'app Stockscreener
5.96
5.85%
-0.37
Dopo l'orario di chiusura:
6.06
0.10
+1.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$6.33
Aprire:
$6.26
Volume 24 ore:
665.91K
Relative Volume:
0.60
Capitalizzazione di mercato:
$247.90M
Reddito:
$134.48M
Utile/perdita netta:
$-38.94M
Rapporto P/E:
-6.2513
EPS:
-0.9534
Flusso di cassa netto:
$-19.34M
1 W Prestazione:
-8.87%
1M Prestazione:
-9.28%
6M Prestazione:
-20.64%
1 anno Prestazione:
-40.52%
Intervallo 1D:
$5.89
$6.325
Intervallo di 1 settimana:
$5.89
$6.655
Portata 52W:
$4.48
$13.22
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
5.96 | 263.29M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
RxSight (NASDAQ: RXST) CFO swaps 258K options, cuts strike to $6.375 with no share change - Stock Titan
RxSight (NASDAQ: RXST) COO swaps high-priced options for new $6.375 grants - Stock Titan
RxSight (RXST) CMO exchanges higher-priced options for new $6.375 grants - Stock Titan
RxSight (NASDAQ:RXST) Faces a Crucial Test on the Road to Scale - Kalkine Media
RxSight at wells fargo healthcare conference: reset centers on LAL growth - Investing.com Canada
RxSight (RXST) ends employee option swap after 91.9% take-up - Stock Titan
RXST stock slips as insider selling and cash level draw attention - AD HOC NEWS
RxSight Officer Mark Wilterding to Sell 7,765 Shares Worth $54,044.40 to Cover Tax Withholding - Kalkine Media
RxSight stock edges higher after insider tax sales and Q2 beat - ad-hoc-news.de
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com South Africa
RxSight COO Ilya Goldshleger sells $14,205 in company stock By Investing.com - Investing.com South Africa
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax By Investing.com - Investing.com Australia
RxSight CFO Mark Wilterding sells $54,044 in company stock - Investing.com
RxSight COO Ilya Goldshleger sells $14,205 in company stock - Investing.com
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax - Investing.com India
RxSight chief business development officer Eric Weinberg sells $14,205 in stock - Investing.com
RxSight (NASDAQ: RXST) officer plans 5,100-share sale to cover taxes - Stock Titan
RSU vesting at RxSight (NASDAQ: RXST) prompts insider share sale - Stock Titan
RxSight (RXST) officer to sell shares for taxes - Stock Titan
RxSight (RXST) CFO sells shares to cover RSU taxes - Stock Titan
RxSight (RXST) CMO vests 13,425 units, sells shares for taxes - Stock Titan
RxSight (RXST) COO sells 2,041 shares after RSU vest - Stock Titan
RxSight (RXST) exec’s stock sale only covers taxes - Stock Titan
Price to earnings forward of RxSight, Inc. – NASDAQ:RXST - TradingView
(RXST) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
RxSight stock holds in the lower single digits as losses narrow on stronger quarterly revenue - ad-hoc-news.de
RxSight management is scheduled to speak in Boston on Sept. 9 - Stock Titan
RxSight (NASDAQ: RXST) refreshes documents for option exchange - Stock Titan
Tocqueville Asset Management L.P. Makes New Investment in RxSight, Inc. $RXST - MarketBeat
Steven Cohen’s Point72 discloses RxSight (RXST) stake - Stock Titan
RxSight (RXST) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Price Move - vinanet.vn
RxSight (RXST) Market: Moves 1.88% Higher to $6.49 in the Current Update; Boundary Watch: Support at $6.17 and Resistance at $6.81 Frame the Range on the DayATR Trailing Stop - vinanet.vn
Vitruvian Partners LLP Purchases New Holdings in RxSight, Inc. $RXST - MarketBeat
RxSight (RXST) Quarterly Figures: The Bottom-Line Figure Outpaces Its Comparison in Latest Trading; Price Reaction: The Stock Ends Down 1.70% in the Latest SessionGuidance Upgrade Report - Vinanet
RxSight (NASDAQ: RXST) ex-director to sell 11,890 shares - Stock Titan
Midday Stock Roundup: Eledon Falls 3.5% - Orange County Business Journal
RxSight (RXST) Close and Levels: Loses 2.31% to Close at $6.33 on the Day; Trading Range: Support at $6.01 and Resistance at $6.65 Frame the Range in the Available RecordAnchored VWAP - vinanet.vn
RxSight Inc. (RXST) Drops Nearly 6% as Shares Approach Key SupportMcClellan Summation - Vinanet
RxSight (RXST) Slips to $6.89 as Bearish Momentum Builds in Medical Device StockRVOL Spike - vinanet.vn
Walleye Capital LLC Takes Position in RxSight, Inc. $RXST - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Alcon terminates PowerVision IOL programs, takes $402M write-off - MassDevice
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
RxSight (RXST) Q2 2026 Earnings Call Transcript - AOL.com
(RXST) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development - AOL.com
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Eye care company Alcon raises margin outlook, shares jump - marketscreener.com
Stifel cuts RxSight stock price target on competitive headwinds By Investing.com - Investing.com India
RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges - StreetInsider
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $7.00 - MarketBeat
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):